Ontology highlight
ABSTRACT: Background
Hypothermic machine perfusion (HMP) improves the quality of donor livers for transplantation, both in animal models and in clinical practice. Treatment with SP600125, an inhibitor of c-Jun N-terminal kinase (JNK), can suppress the JNK signaling pathway to alleviate donor liver ischemia-reperfusion injury (IRI). We performed the present study with the objective of exploring the protective effects exerted by a combination of HMP and SP600125 on liver xenograft viability for donation after cardiac death (DCD) in a porcine model.Methods
54 adult BAMA mini-pigs were randomly assigned to 5 groups, including sham, cold storage for 4 h (CS 4 h), CS 4 h?+?SP600125, CS 2 h?+?HMP 2 h, and CS 2 h?+?HMP 2 h?+?SP600125 groups. Donor livers in the CS 4 h and CS 4 h?+?SP600125 groups were conventionally cold preserved for 4 h, whereas donor livers in the CS 2 h?+?HMP 2 h and CS 2 h?+?HMP 2 h?+?SP600125 groups were cold preserved for 2 h and then treated with HMP for 2 h. The preservation and perfusion solutions contained SP600125 (20 µM). Follow-up was conducted for 5 days after liver transplantation to compare the surgical outcomes by means of serological examination, pathological results, and survival rate.Results
The most satisfactory outcome after liver transplantation was observed in the CS 2 h?+?HMP 2 h?+?SP600125 group, which presented with minimal damage of donor livers during 5 days' follow-up. Additionally, serological examination, pathological results, and survival rate concurred in showing better results in the CS 2 h?+?HMP 2 h?±?SP600125 group than in the CS 4 h?±?SP600125 group.Conclusion
HMP in combination with SP600125 has hepatoprotective properties and improves the quality and viability of porcine livers collected after DCD, thus improving prognosis after liver transplantation.
SUBMITTER: Zhang Y
PROVIDER: S-EPMC7863371 | biostudies-literature | 2021 Feb
REPOSITORIES: biostudies-literature
Zhang Yijie Y Pan Qi Q Cheng Ying Y Liu Yongfeng Y
European journal of medical research 20210205 1
<h4>Background</h4>Hypothermic machine perfusion (HMP) improves the quality of donor livers for transplantation, both in animal models and in clinical practice. Treatment with SP600125, an inhibitor of c-Jun N-terminal kinase (JNK), can suppress the JNK signaling pathway to alleviate donor liver ischemia-reperfusion injury (IRI). We performed the present study with the objective of exploring the protective effects exerted by a combination of HMP and SP600125 on liver xenograft viability for dona ...[more]